Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Quote Havasu78 "-CD16 - Slam dunk trial will ta

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155592
(Total Views: 556)
Posted On: 03/24/2021 12:10:42 AM
Avatar
Posted By: Goosebumps
Re: havasu78 #84054
Quote Havasu78

"-CD16 - Slam dunk trial will take care of the above if not granted sooner "

I thought I heard CD12 was a slam dunk.

Based on the under CD12 under 65 data, CD16 certainly appears a slam dunk



We It’s more of a slam dunk because we are not using mortality for a primary end point. We tested very very good for 6 day early release from hospital. That will be our primary end point. New change is adding the break at 65 years old into two trials instead of one to add to the slam dunk. It’s a great idea and I wonder who thought of this? Dr. Kelly? Dr Rahman?

Quote Havasu78

What I fear is that Patterson has lab data which might demonstrate that result but CYDY doesn't want to pay Patterson for the data.


We haven’t needed any lab work from Doctor Patterson’s lab for what? A year?
Last thing we might of needed was RO testing but that wasn’t performed to FDA standards and wasn’t any good for us. That’s why we hired another vendor to accomplish the RO and Nader stated this clearly in the last CC. Also stated that RO testing will be complete soon and we will file HIV BLAs across the board for Duel and Mono by end of July. This is great news and will give us revenue this year in HIV in some locations if approved. My bet is Dr. Rahman slam dunks these HIV BLAs or equivalent in the 4-5 countries we mentioned in the CC.

I am wondering if you listened to the CC for the latest updates. Because the subjects you mentioned were all spoken about in the latest CC. Just thought I would give you a heads up. You can still access the CC on Cytodyn’s web site.

Read More: https://investorshangout.com/post/newpost/605...z6pzxakz8h

Read More: https://investorshangout.com/post/newpost/605...z6pzvqLo85


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us